Session Tracks

This track will explore the latest advancements in cancer classification systems, focusing on molecular and genetic approaches. Participants will discuss the implications of these innovations for personalized treatment strategies.

This session will address the critical role of psychological support in cancer care, emphasizing strategies to enhance patient well-being. Topics will include coping mechanisms, mental health interventions, and the integration of psychological services in oncology.

This track will highlight cutting-edge research in cancer drug discovery, including novel therapeutic agents and drug delivery systems. Discussions will focus on the translation of laboratory findings into clinical applications.

This session will delve into the factors contributing to cancer development, including genetic, environmental, and lifestyle influences. Epidemiological studies and their implications for prevention strategies will be a key focus.

This track will examine the role of genetic testing and risk assessment in cancer prevention and treatment. Participants will discuss the ethical considerations and clinical applications of genetic information in oncology.

This session will cover recent breakthroughs in cancer immunology, including immune checkpoint inhibitors and CAR T-cell therapy. The focus will be on understanding the immune response to tumors and its therapeutic potential.

This track will provide insights into the design and implementation of clinical trials for cancer therapies. Discussions will include challenges in trial recruitment, data management, and regulatory considerations.

This session will explore innovative diagnostic techniques for cancer detection and monitoring, including imaging technologies and biomarker identification. Emphasis will be placed on improving diagnostic accuracy and patient outcomes.

This track will focus on the interplay between experimental and clinical research in oncology. Participants will share findings from preclinical studies and their translation into clinical practice.

This session will address the unique challenges associated with organ-specific cancers, including treatment modalities and patient management. Discussions will highlight recent advances in understanding and treating these cancers.

This track will examine the role of biomarkers in predicting treatment responses and outcomes in cancer therapy. Participants will discuss the development and validation of biomarkers for clinical use.